phenethyl isothiocyanate has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisa, NH; El-Sherbiny, M; Elsherbiny, NM; Khodir, AE; Said, E | 1 |
| Dong, Y; Jiang, Y; Li, F; Lu, R; Wang, S; Xing, G; Yang, B | 1 |
2 other study(ies) available for phenethyl isothiocyanate and Alloxan Diabetes
| Article | Year |
|---|---|
Phenethyl isothiocyanate attenuates diabetic nephropathy via modulation of glycative/oxidative/inflammatory signaling in diabetic rats.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Glutamate-Cysteine Ligase; Glycation End Products, Advanced; Heme Oxygenase (Decyclizing); Inflammation; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Lactoylglutathione Lyase; Liver; Macrophages; Male; NF-E2-Related Factor 2; Oxidative Stress; Protective Agents; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Signal Transduction; Streptozocin; Up-Regulation | 2021 |
Susceptibility to the acute toxicity of acrylonitrile in streptozotocin-induced diabetic rats: protective effect of phenethyl isothiocyanate, a phytochemical CYP2E1 inhibitor.
Topics: Acrylonitrile; Animals; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Isothiocyanates; Male; Rats; Rats, Sprague-Dawley; Reflex, Righting; Seizures; Streptozocin; Survival Rate | 2021 |